Month: August 2022

All cancer patients in Norway who no longer benefit from standard treatment has the right to be considered for inclusion into a clinical trial. As part of this, patients will be offered comprehensive genomic profiling of their tumor. The regional health authorities in Norway decided in 2020 to establish an infrastructure for precision diagnostics (InPreD) …

InPreD at Haukeland University Hospital is open for business! Read More »

We have previously reported that the Regional Health Organizations have approved the opening of the first expansion cohort in IMPRESS-Norway (read more here). Recently, AstraZeneca and IMPRESS-Norway have also entered into an agreement which ensures support for the opening of the first expansion hospital. All the necessary approvals are now in place and the expansion …

The first expansion cohort is ready for inclusion Read More »